Avances en neuroinflamación causada por una lesión local o por trasplante de células madre: implicaciones para la neuroprotección y la traslación clínica

Resumen del proyecto

Neurodegenerative diseases and injuries that cause neuronal death lead to an irreparable loss of function. Beyond the neuronal loss caused by the lesion itself, there is a second slower degeneration caused by over-activated glial cells, i.e. neuroinflammation. This project is divided into three main objectives, related to neuroinflammation. 1/ Most of the preclinical studies en rodents are performed with human mesenchymal stromal cells (MSCs), thus in a xenogeneic scenario. But in the clinic transplants are autologus or allogeneic. The outcome of MSC therapy for the injured central nervous system (CNS) might be highly influenced by glial activation and the subsequent inflammatory response. Thus, our first objective is to analyze the inflammatory and glial in response to MSC therapy, and its effect on neuroprotection. 2/ Unilateral optic nerve axotomy causes neuronal loss in the uninjured contralateral retina, does this response spreads to the rest of the CNS? Our 2nd objective is to study the systemic response and neuroinflammation all across the CNS after injuring a central axonal tract. 3/ As continuation of our previous project we will analyze the signals that make a subtype of retinal ganglion cell resistant to the second phase of axotomy-induced death.

Palabras clave

terapia celular
inflamación
neuroprotección
neurodegeneración

Convocatoria

Acción Estratégica en Salud (AES)

Periodo de ejecución

01/01/2020 - 31/12/2022

Investigador Principal

AGUDO BARRIUSO, MARTA

Centro beneficiario

FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA (FFIS)

Centro de realización

INSTITUTO MURCIANO DE INVESTIGACION BIOSANITARIA (IMIB)

Comunidad Autónoma

MURCIA

Provincia

MURCIA

Financiación

147,620 €